A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
A phase 2 trial of Enzalutamide, Abiraterone acetate, Prednisone in prostate cancer, run by Astellas Pharma Global Development, Inc., active and no longer recruiting.
Overview
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study is a phase 2 interventional study registered as NCT02960022 by Astellas Pharma Global Development, Inc., with 900 participants planned, started 2016-12-22 and due to reach its primary completion in 2029-07-31. Interventions recorded: enzalutamide, abiraterone acetate, prednisone, Leuprolide acetate. Conditions listed: Prostate Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Shares Astellas, Prednisone, Abiraterone acetate, Prostate cancer.
- TrialAn Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormo
Shares Astellas, Enzalutamide, Prostate cancer.
- TrialStudy of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC
Shares Prednisone, Enzalutamide, Abiraterone acetate, Prostate cancer.
- TrialA Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Ver
Shares Prednisone, Abiraterone acetate, Prostate cancer.
- TrialA Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer
Shares Prednisone, Abiraterone acetate, Prostate cancer.
- TrialAn Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Canc
Shares Enzalutamide, Abiraterone acetate, Prostate cancer.
- TrialStudy of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC
Shares Astellas, Enzalutamide, Prostate cancer.
- TrialA Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer
Shares Prednisone, Abiraterone acetate, Prostate cancer.